Mike Wallace applauds while younger man accepts an award, 23 October 1998

Label on back reads : "9810-2307 / 23 October 1998 / UN Photo"

Mike Wallace and unidentified woman holding an award, 23 October 1998

UN Photo

Transcript of proceedings, official papers, and award of the Board of arbitration : appointed under the provisions of the Railway labor act.

Frank M. Williams, official reporter.

In the matter of the arbitration between Transport Workers Union of America, Local 100 and New York City Omnibus Corporation; Fifth Avenue Coach Company; Jamaica Buses, Inc.; Triboro Coach Company; Queens-Nassau Transit Lines, Inc.; Steinway-Omnibus Corporation; Queensboro Bridge Railway Company, Inc.; Avenue B and East Broadway Transit Company, Inc. : opinion and award /

Cover title.

A communication by the directors to the stockholders of the Boston & Worcester railroad corporation, in relation to the late award of commissioners and the strictures of the president of the Western railroad corporation thereon.

Other issues, with same imprint, have 68, [4] and 72 pages, respectively.

Wage scale : award of New York Arbitration Board.

"A small primer of first principles of unionism."

Irreducible cyclic presentations of the trivial group

We produce families of irreducible cyclic presentations of the trivial group. These families comprehensively answer questions about such presentations asked by Dunwoody and by Edjvet, Hammond, and Thomas. Our theorems are purely theoretical, but their derivation is based on practical computations. We explain how we chose the computations and how we deduced the theorems.

A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing

Introduction: Mutation testing for the MEN1 gene is a useful method to diagnose and predict individuals who either have or will develop multiple endocrine neoplasia type 1 ( MEN 1). Clinical selection criteria to identify patients who should be tested are needed, as mutation analysis is costly and time consuming. This study is a report of an Australian national mutation testing service for the MEN1 gene from referred patients with classical MEN 1 and various MEN 1- like conditions. Results: All 55 MEN1 mutation positive patients had a family history of hyperparathyroidism, had hyperparathyroidism with one other MEN1 related tumour, or had hyperparathyroidism with multiglandular hyperplasia at a young age. We found 42 separate mutations and six recurring mutations from unrelated families, and evidence for a founder effect in five families with the same mutation. Discussion: Our results indicate that mutations in genes other than MEN1 may cause familial isolated hyperparathyroidism and familial isolated pituitary tumours. Conclusions: We therefore suggest that routine germline MEN1 mutation testing of all cases of classical'' MEN1, familial hyperparathyroidism, and sporadic hyperparathyroidism with one other MEN1 related condition is justified by national testing services. We do not recommend routine sequencing of the promoter region between nucleotides 1234 and 1758 ( Genbank accession no. U93237) as we could not detect any sequence variations within this region in any familial or sporadic cases of MEN1 related conditions lacking a MEN1 mutation. We also suggest that testing be considered for patients < 30 years old with sporadic hyperparathyroidism and multigland hyperplasia